3 Test Areas to Watch in Point-of-Care Infectious Diseases Testing in Developing Countries

2024-03-30 09:14

  • Point-of-care (POC) diagnostics is a key tool to combat and manage infectious diseases in developing countries. EIU Healthcare expects the use of point-of-care (POC) testing to grow as countries address the rising infectious disease prevalence amid a weak healthcare infrastructure.

    In this infographic, EIU Healthcare picks out high-growth test areas in infectious diseases to watch based on data and forecasts from IVD Gateway, shedding light on where and how companies can help expand access to POC testing in developing countries.

    Download the infographic and find out:

    • 2019-2024 growth forecasts for POC testing in Asia-Pacific (APAC) and Latin America (LATAM)

    • How POC testing will expand testing coverage for HIV and sexually transmitted diseases (STDs) in LATAM by bringing tests to vulnerable and remote populations

    • Which countries in LATAM are expected to experience strong growth (2019-2024) in POC HIV testing, with 2019-2024 growth forecasts

    • How vector-borne diseases such as malaria and dengue will drive fast growth in POC testing for infectious diseases in Asia

    • Which countries in APAC are expected to experience strong growth (2019-2024) in POC malaria testing, with 2019-2024 growth forecasts

    • Percentage of Covid-19 tests needed at POC settings in low-and middle-income countries in 2021

    • How IVD companies can expand access to POC testing in developing countries

    IVD Gateway Size & Share Plus tracks market size, share and growth in 38 countries for all major market segments, including POC test segments. IVD Gateway’s annual data and forecast update (2020-2025) will be available from April 2021.

    Download infographic to learn more about POC infectious disease markets

    Fill out the form to download the infographic.

    From time to time, we would like to contact you with relevant updates, newly released content, events or special offers from The Economist Group.

    By submitting this form, you are agreeing to receive information from Economist Intelligence. At any point you can update your preferences or unsubscribe from communications by clicking the link(s) at the bottom of our emails. Further information about our terms of use and privacy policy can be found here.

    IVD Gateway: IVD Market and Forecasts with Covid-19 Impact

    The go-to-source for Covid-19 impact on In-Vitro Diagnostics test demand in 2020 and market recovery trends in 2021 for all 130+ IVD test segments across countries in Asia, Europe and Latin America.

    Find out more